Medical Knowledge Is Only As Good As It Is Current
Timely physician access to understandable information can make all the difference when exploring treatment recommendations. Learn how our distributed learning system provides evidence-based treatment options with unprecedented ease and clarity.
On Average a Physician Spends Only 11 Minutes With a Patient
Treatment reports are typically manually created, labor intensive and susceptible to inconsistencies. MolecularMatch’s automated platform is continually evolving and performing complex analytics while supporting high patient volume and massive scale sequencing.
What We Do
Clinical Intelligence on Demand
MolecularMatch is a clinical informatics company that has developed a rapid learning system to facilitate superior clinical decision support, continually evolving alongside the field of precision medicine. Health and Life Science organizations like yours can augment their current offerings by incorporating our automated molecular knowledge platform. By partnering with MolecularMatch, we can build a solution customized to your needs and workflow, rather than being limited by outdated software, large consultancy agreements or a set number of service hours. Your company becomes more efficient and competitive by leveraging technology that scales to provide evidence-based recommendations for thousands of patients at a time rather than on a case-by-case basis.
How We Are Different
In the Health and Life Science industry, research and development are becoming more complex and expensive. Organizations are being challenged to become more efficient in a segment crowded with numerous options for clinical research data. Companies often rely on large numbers of scientific staff to manually sift through public databases and siloed repositories. This can lead to inconsistencies and a disparity of clinical recommendations with limited understandable content.
MolecularMatch delivers personalized results at a massive scale that is affordable. Unlike other genomic service-oriented companies, MolecularMatch is a technology company first. Our proprietary technology delivers the deepest and broadest oncology genomic information in a biomedical ontology. We house a collaborative, self-learning tool with Natural Language Processing and machine learning capabilities. Our automated technology reduces the manually intensive processes associated with targeted molecular recommendations, allowing you to be more productive and accurate in your clinical decision making.
Automation, Depth of Knowledge and Ease of Use
400 MILLION+ ALTERATIONS COVERED
Molecular level search engine
Public and private proprietary sources
Unique biomedical ontology
Our comprehensive knowledge base encompasses public and proprietary datasets, connecting you with the largest set of actionable information and eliminating gaps in coverage.
WHOLE EXOME IN SECONDS
Less manually invasive
Real time access
Automated technology provides the most clinically actionable data to users quickly, efficiently and consistently—reducing the manually invasive work typically required to analyze this level of data. When new data becomes available, it can be quickly integrated and utilized.
EXCEEDS REGULATORY STANDARDS
Setting and exceeding industry data standards
Clinical and scientific quality assurance
High data integrity
Quality is the top priority. Data integrity is ensured through multiple iterations of quality control, evidence-based annotations and clinical oversight.
5 INDUSTRIES SERVED AND GROWING!
Map evidence by guidelines
Solutions are configured to your companies philosophy and workflow contributing to greater productivity and efficiency. Our system integrates simply and seamlessly, getting you up and running in no time.
Chief Executive Officer Kevin Coker and Chief Scientific Officer Shirley Li are attending their 3rd ASCO conference to discuss the latest suite of solutions with industry professionals.
CURATING THE CLINICAL GENOME MEETING 2017
Our Knowledge Scientist Ryan Duren will be attending to further cultivate our relationship with ClinGen to discuss further opportunities.
AGBT Precision Health Meeting 2017
Salt Lake City, UT
Chief Scientific Officer Shirley Li will be attending this year's annual AMP meeting.